As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

A scientist has explained how eating it regularly could help reduce the risk, with research showing it may protect against ...

A scientist has discussed how the risk of deadly bowel cancer can be significantly reduced by consuming one item for ...

CHRISTUS Health Cancer Center in Longview, which is set to open later this year, named Steven J. DiBiase as their new medical director on Monday.

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

News.

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Cancer Clinician and Translational Scientist Dr. Daniela Matei will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search, Houston Methodist ...

Are time commitments related to cancer care toxic? Depends on who you ask.The term “time toxicity” has become cancer jargon over the past few years, sparking research into how much time patients spend ...

The study analyzed data from more than 1.8 million people for 16 years ...

Toxicity-related T-DXd discontinuation was 15%, closely aligning with DESTINY-Breast04 (16.2%), supporting feasibility of administration in community oncology despite higher real-world disease burden.

Researchers launch a public immune atlas of pancreatic cancer therapy responses, allowing the public to rapidly link pancreatic cancer immunotherapy trials to immune shifts and outcomes. Imagine ...